IJROBP Journal SA-CME activity for May 1, 2020 reviews the patient-reported outcomes of oligometastatic patients after conventional or stereotactic radiotherapy to bone metastases.
IJROBP Journal SA-CME activity for April 1, 2020 (Volume 106, Issue 5) reviews the optimum dose constraints for the rectum in prostate cancer patients being treated with hypofractionation.
This journal activity provides practitioners with prospective data supporting the use of longer term ADT in men with high-risk prostate cancer even if they are receiving high dose EBRT of HDR brachytherapy.
The dose gradient index (DGI) was developed as a quantitative metric for characterizing radiation dose fall-off with respect to distance away from the outer surface of a target volume [1].
In patients receiving whole brain radiotherapy after surgical resection of brain metastasis, this article addresses the optimal radiotherapy dose for both tumor control and minimization of short and long-term toxicities.
The present CME journal activity provides practitioners with the knowledge about recent developments in clinical literature of radiotherapy for skin cancers.
IJROBP Journal SA-CME activity for January 1, 2020 (Volume 106, Issue 1) allows practitioners to integrate new biology into their thinking about the management of localized breast cancer.
Facebook
Twitter
LinkedIn
Forward
